Johnson & Johnson Reaches $5.5 Billion Talc Settlement to End Decade-Long Litigation
Johnson & Johnson agreed to a $5.5 billion settlement for 76,000 ovarian cancer claims linked to its talc products, aiming to conclude a decade-long legal battle.
READ FULL STORY